SEC Info - Acer Therapeutics Inc. - ‘8-K’ for 1/25/21

SEC Info℠

Home

My Interests

Help

Please Sign In

Acer Therapeutics Inc. – ‘8-K’ for 1/25/21

On: Monday, 1/25/21, at 8:03am ET · For: 1/25/21 · Accession #: 1564590-21-2002 · File #: 1-33004

Previous ‘8-K’: ‘8-K’ on / for 1/15/21 · Next: ‘8-K’ on / for 2/11/21 · Latest: ‘8-K’ on 11/20/23 for 11/17/23 · 12 References:

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/25/21  Acer Therapeutics Inc.            8-K:1,2,8,9 1/25/21    5:364K                                   ActiveDisclosure/FA

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     39K 
 2: EX-10.1     Material Contract                                   HTML     76K 
 3: EX-10.2     Material Contract                                   HTML     19K 
 4: EX-10.3     Material Contract                                   HTML     30K 
 5: EX-99.1     Miscellaneous Exhibit                               HTML     28K

Filing Submission 0001564590-21-002002 – SGML Text

Original SGML Text submitted by:	ActiveDisclosure/FA (as Filing Agent)

To view the SGML, please refresh
this page.

↑Top

Acer Therapeutics Inc. – ‘8-K’ for 1/25/21

On: Monday, 1/25/21, at 8:03am ET · For: 1/25/21 · Accession #: 1564590-21-2002 · File #: 1-33004

Current Report — Form 8-KFiling Table of Contents

To view the SGML, please refresh this page.

Current Report — Form 8-K
Filing Table of Contents

To view the SGML, please refresh
this page.